BOK Financial’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
Other funds holding ANVS
BOK Financial's ANVS Position: Q3 2026 in Review
BOK Financial held its Annovis Bio (ANVS) position steady in Q3 2026 at 555 shares worth $705. The position accounts for ﹤0.01% of the portfolio, ranked #1072.
BOK Financial first reported a position in ANVS in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.45K in Q3 2024. 50 funds tracked by Wall St. Rank hold ANVS as of Q3 2026.
- BOK Financial held 555 shares of Annovis Bio worth $705 as of Q3 2026.
- BOK Financial left its Annovis Bio share count unchanged in Q3 2026.
- Annovis Bio made up ﹤0.01% of BOK Financial's portfolio in Q3 2026, its #1072 holding.
- BOK Financial first reported a position in Annovis Bio in Q3 2024 and has held it in 8 quarters since.
- BOK Financial's Annovis Bio position peaked at $4.45K in Q3 2024.
- 50 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2026.
Based on BOK Financial's 13F filing for Q3 2026, filed 27 Oct 2026.